CPHI - China Pharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD

0.2338

-0.0158 (-6.33%)

At close: 3:53PM EDT

Stock chart is not supported by your current browser

Previous Close	0.2496
Open	0.2600
Bid	0.0000 x 4000
Ask	0.0000 x 800
Day's Range	0.2201 - 0.2600
52 Week Range	0.1500 - 1.4500
Volume	206,480
Avg. Volume	136,217

Market Cap	10.189M
Beta	2.88
PE Ratio (TTM)	N/A
EPS (TTM)	-0.4270
Earnings Date	Mar 29, 2018 - Apr 2, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	3.00

Trade prices are not sourced from all markets

All

News

Press Releases

PR Newswire23 hours ago
China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results
HAIKOU CITY, China , Aug. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation ...
PR Newswire10 days ago
CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET
HAIKOU, China , Aug. 6, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals ...
Investopedia24 days ago
Top 3 Healthcare Penny Stocks for 2018
The healthcare industry can be precarious for stocks of large companies, much less penny stocks. Of course, small-cap healthcare companies can be nudged out of the market by big competitors, and they can simply become unable to service debt when products and services don't sell quickly enough. None of these are new companies – they have made progress in developing products and finding the marketing outlets that are needed to sustain them.
ACCESSWIRE3 months ago
Free Stock Performance Review on Pfizer and Three More Drug Makers’ Stocks
Stock Research Monitor: AZN, CPHI, and MRK LONDON, UK / ACCESSWIRE / May 15, 2018/ If you want a free Stock Review on PFE sign up now at www.wallstequities.com/registration . This morning, WallStEquities.com ...
PR Newswire3 months ago
China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results
HAIKOU, China , May 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with ...
Investopedia3 months ago
Top 3 Healthcare Penny Stocks for 2018
The healthcare industry can be precarious for stocks of large companies, much less penny stocks. Of course, small-cap healthcare companies can be nudged out of the market by big competitors, and they can simply become unable to service debt when products and services don't sell quickly enough. None of these are new companies – they have made progress in developing products and finding the marketing outlets that are needed to sustain them.
PR Newswire3 months ago
CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET
HAIKOU, China , May 8, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary ...
ACCESSWIRE4 months ago
Wired News – Eli Lilly's Phase-3 REACH-2 Study of CYRAMZA(R) Met its Primary Endpoint of Overall Survival
Stock Monitor: China Pharma Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 6, 2018 / Active-Investors.com has just released a free research report on Eli Lilly and Co. (NYSE: LLY ) ("Eli ...
Investopedia4 months ago
Top 3 Healthcare Penny Stocks for 2018
These three healthcare penny stocks are poised for positive performance in 2018.
ACCESSWIRE4 months ago
Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD
Stock Monitor: China Pharma Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 05, 2018 / Active-Investors.com has just released a free research report on Tonix Pharma Holding Corp. (NASDAQ: ...
PR Newswire4 months ago
China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results
HAIKOU, China , April 3, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with ...
PR Newswire5 months ago
CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET
HAIKOU CITY, China , March 22, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals ...
Investopedia5 months ago
Top 3 Healthcare Penny Stocks for 2018
These three healthcare penny stocks are poised for positive performance in 2018.
Investopedia6 months ago
Top 3 Healthcare Penny Stocks for 2018
These three healthcare penny stocks are poised for positive performance in 2018.
Investopedia8 months ago
Top 3 Healthcare Penny Stocks for 2017
These three healthcare penny stocks are poised for positive performance in the remainder of 2017.
PR Newswire9 months ago
China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results
HAIKOU CITY, China , Nov. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation ...
Investopedia9 months ago
Top 3 Healthcare Penny Stocks for 2017
These three healthcare penny stocks are poised for positive performance in the remainder of 2017.
PR Newswire9 months ago
CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET
HAIKOU CITY, China , Nov. 7, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals ...
Simply Wall St.10 months ago
Does China Pharma Holdings Inc’s (CPHI) Debt Level Pose A Serious Problem?
Investors are always looking for growth in small-cap stocks like China Pharma Holdings Inc (AMEX:CPHI), with a market cap of USD $6.75M. However, an important fact which most ignore is:Read More...
Investopedia10 months ago
Top 3 Healthcare Penny Stocks for 2017
These three healthcare penny stocks are poised for positive performance in the remainder of 2017.
Simply Wall St.11 months ago
China Pharma Holdings Inc (CPHI): What Does It Mean For Your Portfolio?
If you are a shareholder in China Pharma Holdings Inc’s (AMEX:CPHI), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile ofRead More...
ACCESSWIRE11 months ago
Corporate News Blog - GlaxoSmithKline Declares Publication of Phase-III Results Of Mepolizumab in Patients with Eosinophilic COPD at Risk of Exacerbations
Research Desk Line-up: China Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 14, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...
PR Newswire11 months ago
China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency
HAIKOU, China, Sept. 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company") today announced receipt of notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") that the Company is not in compliance with certain NYSE American continued listing standards or the Listing Standards. The Deficiency Letter indicated that the Company's securities have been selling for a low price per share for a substantial period of time and, most recently, the average price of the Company's common stock had been below $0.20 on a 30-day average as of September 5, 2017. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the NYSE American staff determined that the Company's continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the staff determined to be until March 6, 2018.
Capital Cubelast year
China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
Categories: Yahoo FinanceGet free summary analysis China Pharma Holdings, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of China Pharma Holdings, Inc. – Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Dr. Reddy’s Laboratories Ltd. Sponsored ADR, China Biologic Products Holdings, Inc., Novartis AG Sponsored ... Read more (Read more...)